Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Schwab Fundamental U.S. Small Company ETF (FNDA), a passively managed exchange traded fund ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $44.43, representing a +2.87% change from its previous close.

Global Serotonin Supplement Market is valued at approximately USD 945.23 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.58% over the forecast period 2024-2032.

All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.

UBS analysts said in a note Monday that markets tend to overreact to geopolitical shocks, and the current Middle East tensions may be no exception.